This federal contract award, valued at $2,317.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a prescription medication, and has an ultimate completion date of December 9, 2024. This contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has been registered in the System for Award Management (SAM.gov) since 2002. The company maintains significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000, respectively, for providing a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs.
Generated 3/7/25, 9:42 AM